{"id":"arxiv:2509.19536","kind":"article","title":"Integrating Mechanistic Modeling and Machine Learning to Study CD4+/CD8+ CAR-T Cell Dynamics with Tumor Antigen Regulation","authors":["Saranya Varakunan","Melissa Stadt","Mohammad Kohandel"],"author_count":3,"year":2025,"published":"2025-09-23","venue":"Bulletin of Mathematical Biology","cited_by":1,"doi":"10.1007/s11538-026-01633-3","arxiv_id":"2509.19536","nct_id":null,"source_url":"https://arxiv.org/abs/2509.19536","archive_url":"https://space-kitty.com/papers/arxiv:2509.19536","updated":"2026-03-10","pmid":null,"pmcid":null,"openalex_id":"W7140341693","pdf_url":"https://arxiv.org/pdf/2509.19536","abstract":"Chimeric antigen receptor (CAR) T cell therapy has shown remarkable success in hematological malignancies, yet patient responses remain highly variable and the roles of CD4+ and CD8+ subsets are not fully understood. We present an extended mathematical framework of CAR-T cell dynamics that explicitly models CD4+ helper and CD8+ cytotoxic lineages and their interactions with tumor antigen burden. Building on the Kirouac et al. (2023) model of antigen-regulated memory-effector-exhaustion transitions, our system of differential equations incorporates CD4-mediated modulation of CD8+ proliferation, cytotoxicity, and memory regeneration through biologically grounded, saturating interactions. Sensitivity analyses identify effector proliferation, antigen turnover, and CD8+ expansion rates as dominant drivers of treatment outcome. Virtual patient simulations recover reported qualitative trends in CAR-T composition, including enhanced expansion and tumor clearance for defined CD4:CD8 products relative to CD8-only formulations, while also revealing inter-patient variability and time-dependent effects. To assess the practical limits of patient-level prediction under parameter uncertainty, we introduce controlled noise into key parameters and show that direct mechanistic classification rapidly degrades. We then demonstrate that a simple feed-forward neural network can partially recover predictive signal from noisy inputs, outperforming a naive baseline while remaining consistent with mechanistic sensitivities. This work positions the extended model as a hypothesis generator, and illustrates how data-driven methods can complement mechanistic modeling when parameter uncertainty constrains predictive confidence.","abstract_license":"CC0-1.0 (arXiv descriptive metadata)","license":null,"is_open_access":false,"retracted":false,"peer_reviewed":null,"categories":["q-bio.QM","q-bio.CB"],"details":null,"provenance":"arxiv","attribution":"Abstract: arXiv descriptive metadata (CC0). Thank you to arXiv for use of its open access interoperability. This service was not reviewed or approved by, nor does it necessarily express or reflect the policies or opinions of, arXiv.","topics":[{"slug":"cancer-immunotherapy","name":"Cancer Immunotherapy","domain_slug":"medicine"}],"cited_in_dossiers":[]}